Medtronic's Abre Venous Stent Launched in Europe

 

December 21, 2017—Medtronic's Abre self-expanding stent system is now fully launched in Europe. The Abre device, which is intended for use in the iliofemoral veins to treat symptomatic venous outflow obstruction, received European CE Mark approval in April 2017. Medtronic advised that the Abre stent is an investigational device and not available for commercial use in the United States.

According to the company, the Abre stent was designed for the unique challenges of deep venous disease. The Abre stent comes premounted on a 9-F delivery system and features a nitinol stent with a triaxial shaft design. The stent utilizes an open-cell design with three connection points between the cells that are intended to improve flexibility and conformability. Upon deployment, Abre exerts an outward force to open the vein.

The device is offered in a full range of sizes specifically tailored for the iliofemoral venous profile, with a catheter length of 90 cm that supports all three access sites and can be used with a standard-length guidewire, stated Medtronic.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.